Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia 2Stomach Neoplasms 1Small Cell Lung Carcinoma 1Pyloric Stenosis, Hypertrophic 1Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Esophageal Neoplasms 1Carcinoma, Basal Cell 1Bronchiolitis Obliterans Syndrome 1

Interventions

Lenalidomide 2tafasitamab 1brivanib 1Valganciclovir 1N,N-dicyclopropyl-4-((1,5-dimethyl-1H-pyrazol-3-yl)amino)-6-ethyl-1-methyl-1,6-dihydroimidazo(4,5-d)pyrrolo(2,3b)pyridine-7-carboxamide 1Leucovorin 1Irinotecan 1Fluorouracil 1Dexamethasone 1Bortezomib 1BMS-833923 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Pyloric Stenosis, Hypertrophic × BMS-833923 × Clear all
NCT00884546 2016-09-30

Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma

Bristol-Myers Squibb

Phase 1 Completed
27 enrolled

Pyloric Stenosis, Hypertrophic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡